$GATO
Gatos Silver, Inc. Stock $gato

$gato Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000162828023037082 Filed on November 06, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q4
Revenue		$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin		$7.490M	$8.500M
YoY Change		26.31%	130.35%
% of Gross Profit
Research & Development		$0.00	$0.00
YoY Change			-100.0%
% of Gross Profit
Depreciation & Amortization		$0.00	$50.00K
YoY Change		-100.0%	25.0%
% of Gross Profit
Operating Expenses		$7.497M	$8.550M
YoY Change		25.43%	114.29%
Operating Profit
YoY Change
Interest Expense		$9.110M	$12.62M
YoY Change		3.64%	-36.99%
% of Operating Profit
Other Income/Expense, Net		$1.348M	$1.620M
YoY Change		25.28%	1.89%
Pretax Income		$3.288M	-$2.210M
YoY Change		-18.39%	-96.48%
Income Tax		$0.00	$1.570M
% Of Pretax Income		0.0%
Net Earnings		$3.288M	-$3.770M
YoY Change		73.05%	-93.99%
Net Earnings / Revenue
Basic Earnings Per Share		$0.05
Diluted Earnings Per Share		$0.05	-$0.05
COMMON SHARES
Basic Shares Outstanding	69.16M shares	69.16M
Diluted Shares Outstanding		69.52M shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments		$33.50M	$17.00M
YoY Change		118.95%	157.58%
Cash & Equivalents	$55.48M	$33.47M	$17.00M
Short-Term Investments
Other Short-Term Assets	$22.64M	$15.94M	$16.87M
YoY Change	34.21%	1379.57%	374.17%
Inventory
Prepaid Expenses	$1.914M	$816.0K	$2.890M
Receivables
Other Receivables
Total Short-Term Assets	$78.69M	$50.50M	$35.65M
YoY Change	120.73%	198.25%	202.97%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$321.9M	$328.7M	$347.8M
YoY Change	-7.44%	-3.63%	4.32%
Other Assets	$38.00K	$42.00K	$60.00K
YoY Change	-36.67%	7.69%	71.43%
Total Long-Term Assets	$322.2M	$328.8M	$347.9M
YoY Change	-7.37%	-11.5%	-2.11%
TOTAL ASSETS
Total Short-Term Assets	$78.69M	$50.50M	$35.65M
Total Long-Term Assets	$322.2M	$328.8M	$347.9M
Total Assets	$400.9M	$379.3M	$383.5M
YoY Change	4.54%	-2.36%	4.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.713M	$1.075M	$586.0K
YoY Change	362.97%	21.2%	198.98%
Accrued Expenses	$3.031M	$4.200M	$2.761M
YoY Change	9.78%	1063.43%	343.18%
Deferred Revenue
YoY Change
Short-Term Debt		$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities		$26.40M	$26.40M
YoY Change		1047.83%	1785.71%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00	$8.700M
YoY Change		-100.0%	-30.95%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities		$0.00	$8.700M
YoY Change		-100.0%	-30.95%
TOTAL LIABILITIES
Total Short-Term Liabilities		$26.40M	$26.40M
Total Long-Term Liabilities		$0.00	$8.700M
Total Liabilities		$26.40M	$35.00M
YoY Change		74.83%	150.0%
SHAREHOLDERS EQUITY
Retained Earnings	-$185.9M	-$198.2M	-$198.7M
YoY Change	-6.47%	14.87%	4.13%
Common Stock	$117.0K	$117.0K	$117.0K
YoY Change	0.0%	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$367.5M	$352.9M	$348.5M
YoY Change
Total Liabilities & Shareholders Equity	$400.9M	$379.3M	$383.5M
YoY Change	4.54%	-2.36%	4.46%

Cashflow Statement

Concept	2023 Q3	2022 Q4
OPERATING ACTIVITIES
Net Income	$3.288M	-$3.770M
YoY Change	73.05%	-93.99%
Depreciation, Depletion And Amortization	$0.00	$50.00K
YoY Change	-100.0%	25.0%
Cash From Operating Activities	-$1.670M	$5.870M
YoY Change	-120.9%	-197.83%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$30.00K
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$35.00M	$0.00
YoY Change
Cash From Investing Activities	$35.00M	-$30.00K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-9.000M	-4.110M
YoY Change		-2155.0%
NET CHANGE
Cash From Operating Activities	-1.670M	5.870M
Cash From Investing Activities	35.00M	-30.00K
Cash From Financing Activities	-9.000M	-4.110M
Net Change In Cash	24.33M	1.730M
YoY Change	204.51%	-129.83%
FREE CASH FLOW
Cash From Operating Activities	-$1.670M	$5.870M
Capital Expenditures	$0.00	$30.00K
Free Cash Flow	-$1.670M	$5.840M
YoY Change	-120.9%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	42000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	60000	usd
CY2023Q3	us-gaap	Assets Assets	379250000	usd
CY2022Q4	us-gaap	Assets Assets	383501000	usd
CY2023Q3	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	26363000	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	26358000	usd
CY2023Q3	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	0	usd
CY2022Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	8661000	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	700000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	700000000	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	69162223	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	69162223	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	117000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	117000	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	550989000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	547114000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-198219000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-198749000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	352887000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	348482000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	379250000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	383501000	usd
CY2023Q3	us-gaap	Exploration Expense ExplorationExpense	0	usd
CY2022Q3	us-gaap	Exploration Expense ExplorationExpense	0	usd
CY2023Q3	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	3000	usd
CY2022Q3	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	44000	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	7497000	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	5977000	usd
CY2023Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	9437000	usd
CY2022Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	8930000	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1348000	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1076000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3865000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3332000	usd
CY2023Q3	gato	Equity Method Investments And Nonoperating Income Loss EquityMethodInvestmentsAndNonoperatingIncomeLoss	10785000	usd
CY2022Q3	gato	Equity Method Investments And Nonoperating Income Loss EquityMethodInvestmentsAndNonoperatingIncomeLoss	10006000	usd
	gato	Equity Method Investments And Nonoperating Income Loss EquityMethodInvestmentsAndNonoperatingIncomeLoss	19787000	usd
	gato	Equity Method Investments And Nonoperating Income Loss EquityMethodInvestmentsAndNonoperatingIncomeLoss	27859000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3288000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4029000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	865000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	3288000	usd
	us-gaap	Net Income Loss NetIncomeLoss	530000	usd
	us-gaap	Net Income Loss NetIncomeLoss	9785000	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.14
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	69162223	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	69162223	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	69162223	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	69162223	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	69524838	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	69309019	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	69381222	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	69309019	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	348482000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	783000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	835000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	350100000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	416000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	346923000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	3288000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	352887000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	331222000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1482000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	1050000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	333754000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	-250000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	5231000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	338735000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	739000	usd
	us-gaap	Net Income Loss NetIncomeLoss	530000	usd
	us-gaap	Net Income Loss NetIncomeLoss	9785000	usd
	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	74000	usd
	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	132000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	3327000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2099000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-837000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-180000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	15922000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	24527000	usd
	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	0	usd
	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	16776000	usd
	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	-678000	usd
	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	-1006000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	5000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	748000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-936000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-2481000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9535000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	8680000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	27000	usd
	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	35000000	usd
	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	35000000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-27000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	9000000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-9000000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	16465000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	8653000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17004000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6616000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	33469000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15269000	usd
	us-gaap	Interest Paid Net InterestPaidNet	417000	usd
	us-gaap	Interest Paid Net InterestPaidNet	385000	usd
	gato	Interest Earned Excluding Capitalized Interest Operating Activities InterestEarnedExcludingCapitalizedInterestOperatingActivities	690000	usd
	gato	Interest Earned Excluding Capitalized Interest Operating Activities InterestEarnedExcludingCapitalizedInterestOperatingActivities	49000	usd
CY2023Q3	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	826000	usd
CY2022Q4	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	730000	usd
CY2023Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	816000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2890000	usd
CY2023Q3	us-gaap	Insurance Settlements Receivable Current InsuranceSettlementsReceivableCurrent	14200000	usd
CY2022Q4	us-gaap	Insurance Settlements Receivable Current InsuranceSettlementsReceivableCurrent	13100000	usd
CY2023Q3	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	93000	usd
CY2022Q4	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	151000	usd
CY2023Q3	us-gaap	Other Assets Current OtherAssetsCurrent	15935000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	16871000	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	39000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	39000	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	39000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	122000	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1075000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	586000	usd
CY2023Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2363000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2761000	usd
CY2023Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1886000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1889000	usd
CY2023Q3	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	21000000	usd
CY2022Q4	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	21000000	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	39000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	122000	usd
CY2023Q3	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	26363000	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	26358000	usd
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	700000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	700000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation	2122000	usd
CY2022Q3	us-gaap	Share Based Compensation ShareBasedCompensation	739000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	3327000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2099000	usd
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	470574	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0174
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0439
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments	0	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments	0	usd
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.6075
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.5767
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	3288000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	3504000	usd
	us-gaap	Net Income Loss NetIncomeLoss	530000	usd
	us-gaap	Net Income Loss NetIncomeLoss	9785000	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	69162223	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	69162223	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	69162223	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	69162223	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	69524838	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	69309019	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	69381222	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	69309019	shares
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.14
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7494000	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5933000	usd
CY2023Q3	us-gaap	Adjustment For Amortization AdjustmentForAmortization	3000	usd
CY2022Q3	us-gaap	Adjustment For Amortization AdjustmentForAmortization	44000	usd
CY2023Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	9437000	usd
CY2022Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	8930000	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1348000	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1076000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	525000	usd
CY2023Q3	us-gaap	Assets Assets	379250000	usd
CY2022Q3	us-gaap	Assets Assets	358042000	usd
	us-gaap	Exploration Expense ExplorationExpense	26000	usd
	us-gaap	Exploration Expense ExplorationExpense	110000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	19157000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	16967000	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	74000	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	132000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	15922000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	24527000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3865000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3332000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	865000	usd
CY2023Q3	us-gaap	Assets Assets	379250000	usd
CY2022Q3	us-gaap	Assets Assets	358042000	usd

Files In Submission

Name	View Source	Status
0001628280-23-037082-index-headers.html	Edgar Link	pending
0001628280-23-037082-index.html	Edgar Link	pending
0001628280-23-037082.txt	Edgar Link	pending
0001628280-23-037082-xbrl.zip	Edgar Link	pending
ceocert10-q2023q3.htm	Edgar Link	pending
cfocert10-q2023q3.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
gato-20230930.htm	Edgar Link	pending
gato-20230930.xsd	Edgar Link	pending
gato-20230930_g1.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
gato-20230930_cal.xml	Edgar Link	unprocessable
gato-20230930_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
gato-20230930_lab.xml	Edgar Link	unprocessable
gato-20230930_pre.xml	Edgar Link	unprocessable
gato-20230930_htm.xml	Edgar Link	completed
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
soxcert10-q2023q3.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GATO
Gatos Silver, Inc. Stock $gato

2023 Q4 Form 10-Q Financial Statement

#000162828023037082 Filed on November 06, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GATO Gatos Silver, Inc. Stock $gato

2023 Q4 Form 10-Q Financial Statement

#000162828023037082 Filed on November 06, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GATO
Gatos Silver, Inc. Stock $gato